BOT 1.39% 35.5¢ botanix pharmaceuticals ltd

Clinical indications for this novel medicine will expand.Sweaty...

  1. 29 Posts.
    lightbulb Created with Sketch. 8
    Clinical indications for this novel medicine will expand.

    Sweaty hands, feet, legs, cholinergic urticaria, excess secretions, bronchospasm, colic, pupillary dilation, motion sickness etc

    Botanix market cap of $20B on the back of this clinically useful ultra-short acting anticholinergic.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
-0.005(1.39%)
Mkt cap ! $642.5M
Open High Low Value Volume
36.5¢ 37.0¢ 35.0¢ $1.693M 4.721M

Buyers (Bids)

No. Vol. Price($)
2 40362 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 50704 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.